tiprankstipranks
Trending News
More News >
Inhibrx Biosciences Inc (INBX)
NASDAQ:INBX
US Market

Inhibrx Biosciences Inc (INBX) Similar Stocks

Compare
53 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Inhibrx Biosciences Inc
$82.21
$1.22B
457.36%
Prothena
$10.33
$600.74M
-2.14
-25.20%
3 Buy
1 Hold
1 Sell
Moderate Buy
CytomX Therapeutics
$4.06
$660.80M
9.71
222.22%
6 Buy
1 Hold
0 Sell
Strong Buy
Humacyte
$1.31
$237.83M
-69.32%
4 Buy
0 Hold
0 Sell
Strong Buy
Monte Rosa Therapeutics
$16.56
$1.11B
56.42
94.59%
4 Buy
0 Hold
0 Sell
Strong Buy
Candel Therapeutics
$6.47
$310.72M
-33.98%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INBX
Inhibrx Biosciences Inc
82.21
67.46
457.36%
PRTA
Prothena
10.33
-3.48
-25.20%
CTMX
CytomX Therapeutics
4.06
2.94
262.50%
HUMA
Humacyte
1.31
-2.77
-67.89%
GLUE
Monte Rosa Therapeutics
16.56
8.77
112.58%
CADL
Candel Therapeutics
6.47
-3.33
-33.98%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts